JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.135, sa.1, ss.141-148, 2009 (SCI-Expanded)
Background There is scarce data on the outcome of young patients aged 35 years and younger, who have been treated with neoadjuvant chemotherapy. The aim of this study is to evaluate the impact of body mass index (BMI) and various prognostic factors on pathologic response and survival in young patients with localized breast cancer.